Акне: не только косметическая проблема
Abstract
Acne vulgaris is one of the most common skin diseases. The well-known association of acne and hyperandrogenia justifies the use of combined oral contraceptives in the therapy of this disease. Topical therapy is also used to treat acne. The purpose of this study was to optimize the treatment of patients with acne on the basis of comparing the effectiveness of this two approaches in the treatment. The study involved 67 patients 18-25 years old with acne of mild to moderate severity, who received treatment depending on the initial status and reproductive plans. As a result of the study, an algorithm for differentiating the treatment for patients with mild or moderate acne was developed.
References
1. Аравийская Е. Р. Современный взгляд на лечение акне: состояние проблемы и новые возможности // Леч. врач. 2003; (4): 4 - 6.
2. Горячкина М. В., Белоусова Т. А. Современные представления о патогенезе, клинике и терапии акне у женщин // РМЖ. 2012. № 22. С. 1153.
3. Доброхотова Ю. Э., Джобава Э. М., Рагимова З. Ю. и др. Синдром гиперандрогении в практике акушера-гинеколога, дерматолога, эндокринолога: руководство для врачей. - М.: ГЭОТАР-Медиа, 2009.
4. Кубанова А. А., Аравийская Е. Р., Соколовский Е. В., Дворова Е. К., Фадеева Е. И. Системное лечение тяжелых форм акне: опыт использования изотретиноина в российской федерации // Вестник дерматологии и венерологии. 2013; (5): 102-114.
5. Мордовцев В. Н., Селина В. Ю. К вопросу о местном лечении обычных угрей // РМЖ. 2001; (11): 480.
6. Хурасева А. Б. Поиски путей коррекции синдрома гиперандрогении у девочек, рожденных с большой массой тела // Акушерство и гинекология. 2009; (5): 68-71.
7. Юцковская Я. А., Юцковский А. Д., Маслова Е. В., Метляева Н. Б. Опыт междисциплинарного подхода к терапии и косметологической реабилитации кожи пациентов с угревой болезнью // Вестник дерматологии и венерологии. 2005; (2): 32-35.
8. Amado J.M., Matos M.E., Abreu A.M., Loureiro L., Oliveira J., Verde A., et al. The prevalence of acne in the north of Portugal. J Eur Acad Dermatol Venereol. 2006; 20; 1287-1295.
9. Collier C. N., Harper J. C., Cantrell W. C. The prevalence of acne in adults 20 years and older // J Am Acad Dermatol. 2008; 58: 56-59 [PubMed].
10. Dawson A., Dellavalle R. Acne vulgaris. BMJ 2013; 8: 346.
11. Del Rosso J. Q., Bikowski J., Baum E. Prevalence of truncal acne vulgaris: a population study based on private practice experience // J. Am. Acad. Dermatol. 2007. Vol. 56. AB3.
12. Dumont-Wallon G., Dreno B. Specificity of acne in women older than 25 years // Presse Med. 2008. Vol.37. P. 585-591.
13. Gollnik H., Cunliffe W., Berson D. et al. Management of acne: a report from a Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol 2003. 49 (I Suppl): 1-37.
14. Koltun W., Lucky A.W., Thiboutot D., et al. Efficacy and safety of 3 mg drospirenone / 20 mcg ethinylestradiol oral contraceptive administered in 24/4 regimen in the treatment of acne vulgaris: A randomized, double-blind, placebo-controlled trial. Contraception 2008; 77: 249-256.
15. Nijsten T., Rombouts S., Lambert J. Acne is prevalent but use of its treatments is infrequent among adolescents from the general population. J Eur Acad Dermatol Venereol. 2007; 21; 163-168.
16. Rabe T., Luxembourg B., Ludwig M. et al. Contraception and Thrombophilia - a statement from the German Society for Gynecological Endocrinology and Reproductive Medicine (DGGEF e.V.) and the Professional Association of German Gynaecologists (BVF e.V.) // J. Reproduktion med. Endokrinol. 2011; 8 (1): 178-218.
17. Rivera R., Guerra A. Management of acne in women over 25 years of age // Actas Dermosifiliogr. 2009. Vol. 100. P. 33-37.
18. Schramm G., Steffens D. A 12-months evaluation of the CMA-containing oral contraceptive Belara: efficacy, tolerability andantiandrogenic properties. Contraception. 2003; 67 (4): 305-12.
19. Schramm G.A., Schrah G. The efficacy and safety of an oral contraceptive containing chlormadinone acetate: results of a pooled analysis of noninterventional trials in adult and adolescent women. Contraception 2011; 84 (4): 390-401.
20. Seirafi H., Farnaghi F., Vasheghani-Farahani A. et al. Assessment of androgens in women with adultonset acne // Int. J. Dermatol. 2007. Vol. 46. P. 1188-1191.
21. Terouanne B., Paris F., Servant N., Georget V., Sultan C. Evidence that ehlormadinone acetate exhibits antiandrogenic activity in androgen-dependent cell line. Mol Cell Endocrinol. 2002 Dec 30; 198 (1-2): 143-7.
22. Williams C., Layton A. M. Persistent acne in women: implications for the patient and for therapy // Am. J. Clin. Dermatol. 2006. Vol. 7. P. 281-290.
Review
For citations:
Khuraseva A.B. . Medical alphabet. 2018;2(13):31-34. (In Russ.)
Views:
394
Email this article 